Literature DB >> 19183850

Epilepsy in cerebral glioma: timing of appearance and histological correlations.

Anna Rosati1, Alessia Tomassini, Bianca Pollo, Claudia Ambrosi, Andreas Schwarz, Alessandro Padovani, Bruno Bonetti.   

Abstract

PURPOSE: A prospective study of patients with glioma was carried out. Special attention was paid to the first seizure, to the histology, and to the efficacy and prophylactic role of antiepileptic drugs (AEDs). Prognostic factors were analyzed.
METHODS: Between February 1st 2004 and April 1st 2006 patients who underwent surgical treatment at the Neurosurgery Department of Bolzano for primary or recurrent glioma were prospectively followed until April 1st 2007. Seizures at onset occurring in the absence of interictal epileptiform abnormalities were regarded as remote symptomatic seizures and not treated.
RESULTS: Sixty-four individuals were registered in the study; epilepsy diagnosis was made in 27 cases and in 24 of these seizures were the onset symptom. The correlation with histological grading showed that seizures were more frequent in low-grade glioma and in secondary glioblastoma. Although epilepsy was less frequent in high-grade glioma, in these patients seizures were more difficult to control. Poor seizure control was associated with motor and sensitive focal seizures and presence of neurological deficit. Patients without epilepsy and not taking AEDs never developed seizures during the follow-up. DISCUSSION: Our study clearly shows that epilepsy is more frequent in low-grade gliomas but seizures are more difficult to control in high-grade gliomas. In both cases seizures are a quite exclusive symptom at the onset that never appears during the stable course of the disease. Amongst glioblastoma multiforme (GBM), epilepsy is more frequent in GBM developing through progression from low-grade astrocitoma. Moreover, our study strongly indicates that the prophylactic use of AEDs in glioma is not justified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183850     DOI: 10.1007/s11060-009-9796-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  M J Glantz; B F Cole; P A Forsyth; L D Recht; P Y Wen; M C Chamberlain; S A Grossman; J G Cairncross
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Levetiracetam: preliminary experience in patients with primary brain tumours.

Authors:  G L Wagner; E B Wilms; C A Van Donselaar; Ch J Vecht
Journal:  Seizure       Date:  2003-12       Impact factor: 3.184

3.  Surgery of epilepsy associated with brain tumors.

Authors:  T Rasmussen
Journal:  Adv Neurol       Date:  1975

4.  Epilepsy in association with intracranial tumour.

Authors:  M LUND
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1952

5.  Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).

Authors:  Robert S Fisher; Walter van Emde Boas; Warren Blume; Christian Elger; Pierre Genton; Phillip Lee; Jerome Engel
Journal:  Epilepsia       Date:  2005-04       Impact factor: 5.864

Review 6.  The pathogenesis of tumour associated epilepsy.

Authors:  A Beaumont; I R Whittle
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

7.  Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors.

Authors:  Vitaly Siomin; Lilyana Angelov; Liang Li; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

8.  A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology.

Authors:  J Engel
Journal:  Epilepsia       Date:  2001-06       Impact factor: 5.864

Review 9.  Interactions between antiepileptic and chemotherapeutic drugs.

Authors:  Charles J Vecht; G Louis Wagner; Erik B Wilms
Journal:  Lancet Neurol       Date:  2003-07       Impact factor: 44.182

Review 10.  Epidemiology of primary brain tumors: current concepts and review of the literature.

Authors:  Margaret Wrensch; Yuriko Minn; Terri Chew; Melissa Bondy; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2002-10       Impact factor: 12.300

View more
  23 in total

1.  Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.

Authors:  Andrés F Cardona; Leonardo Rojas; Beatriz Wills; Laura Bernal; Alejandro Ruiz-Patiño; Oscar Arrieta; Enrique Jiménez Hakim; Fernando Hakim; Juan Armando Mejía; Nicolás Useche; Sonia Bermúdez; Hernán Carranza; Carlos Vargas; Jorge Otero; Luis Carlos Mayor; León Darío Ortíz; Sandra Franco; Carlos Ortíz; Miguel Gil-Gil; Carmen Balaña; Zyanya Lucia Zatarain-Barrón
Journal:  J Neurooncol       Date:  2017-11-25       Impact factor: 4.130

Review 2.  Surgical management of high-grade glioma: a standard of care.

Authors:  Colin Watts
Journal:  CNS Oncol       Date:  2012-11

3.  Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.

Authors:  Gan You; Zhi-Yi Sha; Wei Yan; Wei Zhang; Yong-Zhi Wang; Shao-Wu Li; Lin Sang; Zi Wang; Gui-Lin Li; Shou-Wei Li; Yi-Jun Song; Chun-Sheng Kang; Tao Jiang
Journal:  Neuro Oncol       Date:  2011-12-19       Impact factor: 12.300

4.  Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.

Authors:  Roberta Rudà; Alessia Pellerino; Federica Franchino; Cinzia Bertolotti; Francesco Bruno; Francesca Mo; Enrica Migliore; Gianni Ciccone; Riccardo Soffietti
Journal:  J Neurooncol       Date:  2017-10-13       Impact factor: 4.130

5.  Different aquaporin-4 expression in glioblastoma multiforme patients with and without seizures.

Authors:  Gianluca Isoardo; Isabella Morra; Giulia Chiarle; Valentina Audrito; Silvia Deaglio; Antonio Melcarne; Carola Junemann; Michele Naddeo; Maurizio Cogoni; Maria Consuelo Valentini; Andrea Limberti; Federico Faccani; Fabio Malavasi; Giuliano Faccani
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

6.  Management of epilepsy in brain tumors.

Authors:  Marta Maschio; Umberto Aguglia; Giuliano Avanzini; Paola Banfi; Carla Buttinelli; Giuseppe Capovilla; Marina Maria Luisa Casazza; Gabriella Colicchio; Antonietta Coppola; Cinzia Costa; Filippo Dainese; Ornella Daniele; Roberto De Simone; Marica Eoli; Sara Gasparini; Anna Teresa Giallonardo; Angela La Neve; Andrea Maialetti; Oriano Mecarelli; Marta Melis; Roberto Michelucci; Francesco Paladin; Giada Pauletto; Marta Piccioli; Stefano Quadri; Federica Ranzato; Rosario Rossi; Andrea Salmaggi; Riccardo Terenzi; Paolo Tisei; Flavio Villani; Paolo Vitali; Lucina Carla Vivalda; Gaetano Zaccara; Alessia Zarabla; Ettore Beghi
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

7.  Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.

Authors:  Marta Maschio; Loredana Dinapoli; Francesca Sperati; Andrea Pace; Alessandra Fabi; Antonello Vidiri; Paola Muti
Journal:  J Neurooncol       Date:  2010-11-25       Impact factor: 4.130

Review 8.  Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.

Authors:  Roberta Rudà; Lorenzo Bello; Hugues Duffau; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

9.  High dosage of cannabidiol (CBD) alleviates pentylenetetrazole-induced epilepsy in rats by exerting an anticonvulsive effect.

Authors:  Ke Mao; Chao You; Ding Lei; Heng Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 10.  Epilepsy and brain tumors.

Authors:  Dario J Englot; Edward F Chang; Charles J Vecht
Journal:  Handb Clin Neurol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.